Elvira Parravicini is a neonatologist and assistant professor of Clinical Pediatrics at Columbia University. Dr. Parravicini has been working on kidney development. Currently her major research focus is the study of urine NGAL (Neutrophil Gelatinase Associated Lipocalin) as an early biomarker of acute renal failure in very low birth weight infants.
Her main clinical interest is prenatal diagnosis and postnatal treatment of infants with congenital anomalies. Dr Parravicini is a team member of Prenatal Pediatrics at Morgan Stanley Children’s Hospital of NY-Presbyterian, whose aim is caring for babies with abnormalities before and after birth. Her specific focus is following infants who have been prenatally diagnosed with a potential lethal malformation and organizing a plan for comfort care. She is author of several scientific communications, medical articles, and book’s chapters.